SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950172-05-002180
Filing Date
2005-07-11
Accepted
2005-07-11 16:06:01
Documents
1
Effectiveness Date
2005-07-11

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT PURSUANT TO '34 ACT ny550567.txt DEFA14A 22513
  Complete submission text file 0000950172-05-002180.txt   24032
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Filer) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-09114 | Film No.: 05948282
SIC: 2834 Pharmaceutical Preparations